)
IRadimed (IRMD) investor relations material
IRadimed Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record revenue of $21.2 million for Q3 2025, up 16% year-over-year, marking the seventeenth consecutive quarter of record revenue, driven by strong U.S. device sales and disposables.
Net income for Q3 2025 was $5.6 million ($0.43 per diluted share), up 10% year-over-year; non-GAAP diluted EPS was $0.47, up 9% year-over-year.
FDA granted 510(k) clearance for the next-generation MRidium® 3870 IV infusion pump, with initial rollout planned for Q4 2025 and broader distribution in 2026.
Completed transition to a new Orlando facility, now fully operational and supporting record backlog.
Maintained a strong gross margin of 78% in Q3 2025.
Financial highlights
Q3 2025 revenue: $21.2 million (+16% YoY); nine-month revenue: $61.1 million (+13% YoY).
Q3 2025 net income: $5.6 million (+10% YoY); nine-month net income: $16.0 million (+14% YoY).
Q3 2025 non-GAAP net income: $6.1 million (+10% YoY); nine-month non-GAAP net income: $17.8 million (+14% YoY).
Q3 2025 cash flow from operations: $7.0 million; nine-month cash flow from operations: $19.0 million.
Cash and cash equivalents at September 30, 2025: $56.5 million; working capital: $72.1 million.
Outlook and guidance
Raised full-year 2025 revenue guidance to $82.5–$83.5 million; GAAP diluted EPS guidance increased to $1.68–$1.72; non-GAAP diluted EPS to $1.84–$1.88.
Q4 2025 revenue expected at $21.4–$22.4 million; GAAP diluted EPS $0.43–$0.47; non-GAAP diluted EPS $0.47–$0.51.
Limited commercial shipments of the 3870 MRI-compatible IV infusion pump to begin December 2025, with full U.S. rollout in Q1 2026 and significant revenue ramp in H2 2026.
Expect higher revenue and operating expenses for the remainder of 2025, driven by increased sales, marketing, regulatory, and G&A costs.
No material impact expected from recent U.S. tax law changes (OBBBA) on annual effective tax rate.
Next IRadimed earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage